Quality of life and severity of symptoms in gastro-oesophageal reflux disease: A clinical review

European Journal of Surgery

Volumn 166, Issue 7, 2000, Pages 516-525

  Velanovich, Vic ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Antireflux surgery; Gastro oesophageal reflux disease; Medical therapy; Quality of life

Indexed keywords

ACCURACY; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

EID: 0033943580     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241500750008565     Document Type: Review

References (62)

1. 1. Alonso J, Anto JM, Gonzalez M. Measurement of general health status of non-oxygen dependent chronic obstructive pulmonary disease patients. Med Care 1992; 30: MS125-MS135.
2. 2. Blomqvist A, Lonroth H, Dalenback J, Ruth M, Wiklund I, Lundell L. Quality of life assessment after laparoscopic and open fundoplications: results of a prospective, clinical study. Scan J Gastroenterol 1996; 31: 1052-1058.
3. 3. Chal KL, Stacey JH, Sacks GE. The effects of ranitidine on symptom relief and quality of life of patients with gastro-oesophageal reflux disease. Br J Clin Pract 1995; 49: 73-77.
4. 4. Chow W-H, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni Jr JF. The relationship of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474-477.
5. 5. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-687.
6. 6. Dimenas E. Methological aspects of evaluation of quality of life in upper gastrointestinal diseases, Scand J Gastroenterol 1993; 28 (Suppl 199): 18-21.
7. 7. Dupuy HJ. The Psychological General Well-Being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York, USA:LeJacq Publishing, 1984: 170-183.
8. 9. Feinstein AR. An additional basic science for clinical medicine: I. The constraining fundamental paradigms. Ann Intern Med 1983; 99: 393-397.
9. 10. Feinstein AR. An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med 1983; 99: 544-550.
10. 11. Feinstein AR. An additional basic science for clinical medicine: III. The challenges of comparison and measurement. Ann Intern Med 1983; 99: 705-712.
11. 12. Feinstein AR. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med 1983; 99: 843-848.
12. 13. Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I: Applications and issues in assessment. BMJ 1992; 305: 1074-1077.
13. 14. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A. Importance of sensitivity to change as a criterion for selecting health status measures. Qual Health Care 1992; 1: 89-93.
14. 15. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ 1992; 305: 1145-1148.
15. 16. Frimodt-Moller PC, Jensen KM, Iverson P. Analysis of presenting symptoms in prostatism. J Urol 1984; 132: 272-277.
16. 17. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharm Ther 1997; 11: 765-773.
17. 18. Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994; 272: 619-626.
18. 19. Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 1995; 30 (Suppl 210): 38-42.
19. 20. Glise H, Hallerback B, Johansson B. Quality of life assessment in evaluation of laparoscopic Rosetti fundoplication. Surg Endosc 1995; 9: 183-189.
20. 21. Gotley DC, Smithers BM, Rhodes M, Menzies B, Branicki FJ, Nathanson L. Laparoscopic Nissen fundoplication-200 consecutive cases. Gut 1996; 38: 487-491.
21. 22. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
22. 23. Guyatt GH, Cook DJ. Health status, quality of life, and the individual. JAMA 1994; 272: 630-631.
23. 24. Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996; 223: 673-687.
24. 25. Kahrilas PJ. Gastroesophageal reflux disease. JAMA 1996; 276: 983-988.
25. 26. Kirshner B, Guyatt G. A methological framework for assessing health indices. J Chron Dis 1985; 38: 27-36.
26. 27. Low DE. Examination of outcome and cost data of open and laparoscopic antireflux operations at Virginia Mason Medical Center in Seattle. Surg Endosc 1995; 9: 1326-1328.
27. 28. Mathias SD, Castell DO, Elkin EP, Matosian ML. Health-related quality of life of patients with acute erosive reflux esophagitis. Dig Dis Sci 1996; 41: 2123-2129.
28. 29. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-486.
29. 30. McHorney CA, Ware Jr JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-263.
30. 31. McHorney CA, Kosinski M, Ware Jr JE. Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: Results from a national survey. Med Care 1994; 6: 551-567.
31. 32. McHorney CA, Ware Jr JE, Lu JFR, Sherbourne CD. The MOS 36-item health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40-66.
32. 33. Patti MG, De Pinto M, De Bellis M, et al. Comparison of laparoscopic total and partial fundoplication for gastroesophageal reflux. J Gastrointest Surg 1997; 1: 309-315.
33. 34. Patti MG, De Bellis M, De Pinto M, et al. Partial fundoplication for gastroesophageal reflux. Surg Endosc 1997; 11: 445-448.
34. 35. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27 (Suppl): S217-S232.
35. 36. Peters JH, Heimbucher J, Kauer WKH, Incarbone R, Bremner CG, DeMeester TR. Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg 1995; 180: 385-393.
36. 37. Peters JH, DeMeester TR, Crookes P, et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg 1998; 228: 40-50.
37. 38. Peterson WL, Sturdevant RAL, Frankl HD, et al. Healing of duodenal ulcer with an antacid regimen. N Engl J Med 1977; 297: 341-345.
38. 39. Pope II CE. The quality of life following antireflux surgery. World J Surg 1992; 16: 355-358.
39. 40. Pope II CE. Acid-reflux disorders. N Engl J Med 1994; 331: 656-660.
40. 41. Rakic S, Stein HJ, DeMeester TR, Hinder RA. Role of esophageal body function in gastroesophageal reflux disease: implications for surgical management. J Am Coll Surg 1997; 185: 380-387.
41. 42. Rattner DW, Brooks DC. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995; 130: 289-294.
42. 43. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Quality of Life Research 1998; 7: 75-83.
43. 44. Rush DR, Stelmach WJ, Young TL, et al. Clinical effectiveness and quality of life with rantidine vs. placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract 1995; 41: 126-136.
44. 45. Spiegelhalter DJ, Gore SM, Fitzpatrick R, Fletcher AE, Jones DR, Cox DR. Quality of life measures in health care. III. Resource allocation, BMJ 1992; 305: 1205-1209.
45. 46. So JBY, Zeitels SM, Rattner DW. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998; 124: 28-32.
46. 47. Stacey JH, Miocevich ML, Sacks GE. The effect of ranitidine (as effervescent tablets) on the quality of life of GORD patients. Br J Clin Pract 1996; 50: 190-194.
47. 48. Stein HJ, DeMeester TR, Hinder RA. Outpatient physiologic testing and surgical management of foregut motility disorders. Curr Probl Surg 1992; 29: 415-555.
48. 49. Svedlund J, Sjodin I, Dotevall G. GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-134.
49. 50. Tarlov AR, Ware Jr JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study: An application of methods for monitoring the results of medical care. JAMA 1989; 262: 925-930.
50. 51. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996; 334: 835-840.
51. 52. Trus TL, Laycock WS, Branum GD, Waring JP, Hunter JG. Quality of life scores correlate poorly with subjective and objective measurements of gastroesophageal reflux. J Gastrointest Surg,: in press.
52. 53. Trus TL, Laycock WS, Waring JP, Branum GD, Hunter JG. Improvement in quality of life measures after laparoscopic antireflux surgery. Ann Surg 1999; 229: 331-336.
53. 54. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996; 183: 217-224.
54. 55. Velanovich V. Comparison of a generic (SF-36) versus a disease-specific quality of life scale for gastroesophageal reflux disease. J Gastrointest Surg 1998; 2: 141-145.
55. 56. Velanovich V. Laparoscopic versus open surgery: A comparison of quality of life outcomes. Surg Endosc, in press.
56. 57. Velanovich V, Karmy-Jones R. Measuring gastroesophageal reflux disease: relationship between health related quality of life scores and physiologic parameters. Am Surg 1998; 64: 649-653.
57. 58. Velanovich V. Comparison of symptomatic and quality of life outcomes of laparoscopic verus open antireflux surgery. Surgery 1999; 126: 782-789.
58. 59. Velanovich V, Karmy-Jones R. Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease. Surg Endosc,: in press.
59. 60. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106-1110.
60. 61. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
61. 62. Watson RGP, Tham TCK, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the "sensitive oesophagus." Gut 1997; 40: 587-590.
62. 63. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995; 273: 59-65.